Evidence map›Paper›PMID 30006624›Full record

ArticleNature communications2018

Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum.

Shannon L Wolfman, Daniel F Gill, Fili Bogdanic, Katie Long, Ream Al-Hasani, Jordan G McCall, Michael R Bruchas, Daniel S McGehee

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Nicotine addiction: More than just dopamine.Current opinion in neurobiology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shannon L WolfmanCommittee on Neurobiology, University of Chicago, Chicago, IL, 60637, USA.
Daniel F GillCommittee on Neurobiology, University of Chicago, Chicago, IL, 60637, USA.
Fili BogdanicDepartment of Anesthesia & Critical Care, University of Chicago, Chicago, IL, 60637, USA.
Katie LongInterdisciplinary Scientist Training Program, University of Chicago, Chicago, IL, 60637, USA.
Ream Al-HasaniSt. Louis College of Pharmacy, Center for Clinical Pharmacology and Division of Basic Research of the Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Jordan G McCallSt. Louis College of Pharmacy, Center for Clinical Pharmacology and Division of Basic Research of the Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Michael R BruchasDivision of Basic Research, Department of Anesthesiology, Washington University Pain Center, St. Louis, MO, 63110, USA.
Daniel S McGeheeCommittee on Neurobiology, University of Chicago, Chicago, IL, 60637, USA. dmcgehee@uchicago.edu.
University of Chicago · USWashington University in St. Louis · USUniversity of Health Sciences and Pharmacy · US

Funding

DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8M
DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER01DA033396 · NIDA · WASHINGTON UNIVERSITY · PI BRUCHAS, MICHAEL R. · 2013 to 2017
$1.9M
Cellular Basis of Nicotine Induced AversionR01DA036978 · NIDA · UNIVERSITY OF CHICAGO · PI MCGEHEE, DANIEL S · 2014 to 2018
$1.8M
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSR00DA038725 · NIDA · ST. LOUIS COLLEGE OF PHARMACY · PI AL-HASANI, REAM · 2017 to 2019
$747k
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSK99DA038725 · NIDA · WASHINGTON UNIVERSITY · PI AL-HASANI, REAM · 2015 to 2016
$280k
NIDA NIH HHS K99 DA038725NIDA NIH HHS R00 DA038725NIDA NIH HHS R01 DA033396NIDA NIH HHS R01 DA036978NIDA NIH HHS R37 DA033396
6 · The paper itself

Abstract

Nicotine use can lead to dependence through complex processes that are regulated by both its rewarding and aversive effects. Recent studies show that aversive nicotine doses activate excitatory inputs to the interpeduncular nucleus (IPN) from the medial habenula (MHb), but the downstream targets of the IPN that mediate aversion are unknown. Here we show that IPN projections to the laterodorsal tegmentum (LDTg) are GABAergic using optogenetics in tissue slices from mouse brain. Selective stimulation of these IPN axon terminals in LDTg in vivo elicits avoidance behavior, suggesting that these projections contribute to aversion. Nicotine modulates these synapses in a concentration-dependent manner, with strong enhancement only seen at higher concentrations that elicit aversive responses in behavioral tests. Optogenetic inhibition of the IPN-LDTg connection blocks nicotine conditioned place aversion, suggesting that the IPN-LDTg connection is a critical part of the circuitry that mediates the aversive effects of nicotine.

Indexed as

AnimalsAvoidance LearningChannelrhodopsinsElectrodes, ImplantedGABAergic NeuronsGene ExpressionHabenulaInterpeduncular NucleusMaleMiceMice, Inbred C57BLNeural PathwaysNicotineOptogeneticsRewardStereotaxic TechniquesChannelrhodopsinsNicotine

Identifiers

PMID30006624
PMCPMC6045623
OpenAlexW2831267268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.